Jason E Faris1, Matthew R Smith. 1. Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Abstract
PURPOSE OF REVIEW: To summarize the metabolic alterations associated with androgen deprivation therapy (ADT) for prostate cancer and to evaluate the evidence linking ADT with an increased risk of diabetes and cardiovascular disease. RECENT FINDINGS: ADT by either bilateral orchiectomy or treatment with gonadotropin-releasing hormone agonists causes changes in body composition, alterations in lipid profiles, and decreased insulin sensitivity. The spectrum of metabolic changes during ADT is distinct from classically described metabolic syndrome. Population-based, linked cancer registry studies have consistently reported significant associations between ADT and greater risk for diabetes mellitus. Some but not all studies have reported a link between ADT and cardiovascular disease risk. Most studies have reported no increase in cardiovascular mortality following ADT. SUMMARY: ADT appears causally associated with diabetes mellitus. ADT is also linked to cardiovascular morbidity, although there is less evidence that this relationship is causal.
PURPOSE OF REVIEW: To summarize the metabolic alterations associated with androgen deprivation therapy (ADT) for prostate cancer and to evaluate the evidence linking ADT with an increased risk of diabetes and cardiovascular disease. RECENT FINDINGS:ADT by either bilateral orchiectomy or treatment with gonadotropin-releasing hormone agonists causes changes in body composition, alterations in lipid profiles, and decreased insulin sensitivity. The spectrum of metabolic changes during ADT is distinct from classically described metabolic syndrome. Population-based, linked cancer registry studies have consistently reported significant associations between ADT and greater risk for diabetes mellitus. Some but not all studies have reported a link between ADT and cardiovascular disease risk. Most studies have reported no increase in cardiovascular mortality following ADT. SUMMARY:ADT appears causally associated with diabetes mellitus. ADT is also linked to cardiovascular morbidity, although there is less evidence that this relationship is causal.
Authors: Zhao Chen; Michael Maricic; Paul Nguyen; Frederick R Ahmann; Roberta Bruhn; Bruce L Dalkin Journal: Cancer Date: 2002-11-15 Impact factor: 6.860
Authors: J C Smith; S Bennett; L M Evans; H G Kynaston; M Parmar; M D Mason; J R Cockcroft; M F Scanlon; J S Davies Journal: J Clin Endocrinol Metab Date: 2001-09 Impact factor: 5.958
Authors: Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Gerald E Hanks; Miljenko V Pilepich; Howard M Sandler; Matthew R Smith Journal: Eur Urol Date: 2008-01-15 Impact factor: 20.096
Authors: Huei-Ting Tsai; Nancy L Keating; Stephen K Van Den Eeden; Reina Haque; Andrea E Cassidy-Bushrow; Marianne Ulcickas Yood; Matthew R Smith; Arnold L Potosky Journal: J Urol Date: 2014-12-15 Impact factor: 7.450
Authors: Chris Wong; Peggy Chu; Jeremy Teoh; Peter Chiu; C H Yee; Lysander Chau; Marco Chan; Helen Wan; Steven Leung; C F Ng Journal: Int Urol Nephrol Date: 2022-02-25 Impact factor: 2.370
Authors: Christina Wang; Graham Jackson; T Hugh Jones; Alvin M Matsumoto; Ajay Nehra; Michael A Perelman; Ronald S Swerdloff; Abdul Traish; Michael Zitzmann; Glenn Cunningham Journal: Diabetes Care Date: 2011-07 Impact factor: 19.112
Authors: Daniel R Schmidt; Rutulkumar Patel; David G Kirsch; Caroline A Lewis; Matthew G Vander Heiden; Jason W Locasale Journal: CA Cancer J Clin Date: 2021-05-13 Impact factor: 286.130
Authors: S Sattar; K R Haase; C Bradley; E Papadopoulos; S Kuster; D Santa Mina; M Tippe; A Kaur; D Campbell; A M Joshua; C Rediger; O Souied; S Alibhai Journal: Prostate Cancer Prostatic Dis Date: 2021-06-09 Impact factor: 5.455